Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydrolase biosynthesis is a multi-step biological process involving the transcription, translation, and post-translational maturation of enzymes belonging to the hydrolase class (EC 3). This process is particularly specialized for lysosomal acid hydrolases, which undergo unique modifications such as the addition of mannose 6-phosphate (M6P) tags in the Golgi apparatus to facilitate their targeting to lysosomes via specific M6P receptors [11, 12]. In the small intestine, the biosynthesis of hydrolases like lactase-phlorizin hydrolase (LPH) is a critical marker of enterocyte differentiation and is tightly regulated by transcription factors such as GATA-4 and HNF-1α [2, 9, 12]. Dysregulation or defects in the biosynthetic pathway of specific hydrolases can lead to severe pathological conditions, most notably lysosomal storage diseases (LSDs) where enzymes are either not produced, misfolded, or fail to be correctly targeted [8, 11]. Therapeutic interventions often target this process using pharmacological chaperones that stabilize nascent proteins to ensure they reach their functional cellular compartments, or gene-directed enzyme prodrug therapies (GDEPT) that introduce the biosynthetic machinery for specific hydrolases into diseased tissues [5, 6, 8]. While specific proteins within these pathways are therapeutic targets, "Hydrolase biosynthesis" refers to the overarching physiological process rather than a single molecular target.
Pharmacological chaperones (e.g., Migalastat) bind to misfolded or unstable nascent hydrolases in the endoplasmic reticulum, stabilizing their conformation to prevent degradation and promoting their maturation and trafficking to lysosomes [8, 11]. Transcriptional regulators and epigenetic modifiers like histone methyltransferases (e.g., Dot1) or HDAC inhibitors can also modulate the expression levels of hydrolase-encoding genes [3, 4, 14].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrolase biosynthesis.